drugset / Trial / NCT03848871

The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients

NCT03848871 ↗

Phase 4 Completed 20 enrolled Derm Research, PLLC
NaSingle-groupOpen-labelTreatment

Summary

This study seeks to show whether there is a benefit of prescribing Enstilar in the treatment of patients with moderate plaque type psoriasis. Subjects will receive study treatment of Enstilar foam.

Timeline

Start
2017-12-12
Primary completion
2018-11-30
Completion
2018-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriene Other / unclassified — Topical
Subject betamethasone dipropionate Small molecule — Topical

Indications